NCT05914220

Brief Summary

DYNAMIC AI is an MHRA-regulated medical device trial that will examine the feasibility of using AI predictive models within COPD multi-disciplinary team meetings, to allow clinicians to prioritise and optimise COPD management.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
500

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Apr 2023

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2023

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

June 13, 2023

Completed
9 days until next milestone

First Posted

Study publicly available on registry

June 22, 2023

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2024

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2024

Completed
Last Updated

June 22, 2023

Status Verified

June 1, 2023

Enrollment Period

1 year

First QC Date

June 13, 2023

Last Update Submit

June 13, 2023

Conditions

Outcome Measures

Primary Outcomes (3)

  • Acceptability to patients

    Evaluation of acceptability to patients with COPD of presenting live artificial intelligence-based 12-month mortality risk-prediction score from the LenusCOPD AI insights application, to COPD clinicians' multi-disciplinary team meetings in NHS GG\&C : Evaluation will be based on proportion of patients invited who consent to participate in the DYNAMIC-AI study.

    12 months

  • Technical feasibility

    Technical Feasability of presenting live artificial intelligence-based 12-month mortality risk-prediction score from the LenusCOPD AI insights application, to COPD clinicians' multi-disciplinary team meetings in NHS GG\&C: Evaluation of feasibility will be proportion of participants with have adequate source data in LenusCOPD and who have 12-month mortality model-risk scores calculated and presented for MDT review in the AI-insights model app

    12 months

  • Safety

    Safety of presenting live artificial intelligence-based 12-month mortality risk-prediction score from the LenusCOPD AI insights application, to COPD clinicians' multi-disciplinary team meetings in NHS GG\&C Evaluation of safety will be based on occurrence of device-related adverse events and from the prospective evaluation of model risk scores - actions of clinicians based on model risk scores and calibration of predicted events : occurred events

    12 months

Secondary Outcomes (4)

  • acceptability and technical feasibility experience

    12 months

  • Expand dataset for training and validation

    12 months

  • Evaluate technical feasibility and descriptive adoption experience

    12 months

  • preliminary experience and utility dataset

    12 months

Interventions

Predictive AI Model Risk score

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

People with COPD living within NHS Greater Glasgow and Clyde Health Board

You may qualify if:

  • Current active user of NHS Scotland COPD digital service. Resident and under care of NHS GG\&C COPD multidisciplinary team. Consent, access to technology (smartphone, tablet, computer and daily internet access), ability to understand written English and confirmed diagnosis of COPD are requirements for use of the COPD digital service

You may not qualify if:

  • Lack of provision of informed consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Queen Elizabeth University Hospital

Glasgow, Scotland, G51 4TF, United Kingdom

RECRUITING

MeSH Terms

Conditions

Pulmonary Disease, Chronic Obstructive

Condition Hierarchy (Ancestors)

Lung Diseases, ObstructiveLung DiseasesRespiratory Tract DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Central Study Contacts

Jacqueline Anderson

CONTACT

Ruairidh Davison

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 13, 2023

First Posted

June 22, 2023

Study Start

April 1, 2023

Primary Completion

March 31, 2024

Study Completion

August 31, 2024

Last Updated

June 22, 2023

Record last verified: 2023-06

Locations